Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 39,283 TVTX shares, $1.06M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 39,283 | $1.06M |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,250 | n/a |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 14,000 | n/a |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 26,120 | n/a |
| Dec 30, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 4,980 | $199.2K |
| Nov 4, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 5,591 | $195.7K |
| Oct 30, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 2,662 | $79.9K |
| Sep 24, 2025 | Travere Therapeutics, Inc. (TVTX) | Gift | 891 | n/a |
| May 6, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,920 | n/a |
| Feb 13, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | n/a |